Metformin Cancer Lawsuit
In March 2020, the online pharmacy Valisure announced it found high levels of the probable human carcinogen NDMA in the popular type-2 diabetes drug metformin.
Exposure to NDMA over prolonged periods of time or in high and concentrated doses can cause a variety of types of cancer.
Valisure has since filed a Citizen Petition with the the Food and Drug Administration (FDA) requesting the agency recall the contaminated batches of metformin.
In May 2020, the FDA announced its testing had also found high levels of NDMA in certain batches of metformin.
If you or a loved one has been diagnosed with cancer after taking metformin, contact GoldenbergLaw for a free consultation on a metformin lawsuit today. Our Minnesota Cancer Attorneys have over 30 years experience fighting pharmaceutical corporations and will deliver the Gold standard advocacy you deserve.Call 800-903-1643 >
Case Quick Facts
On December 5, 2019, the FDA issued a statement announcing it was investigating the presence of possible carcinogens in metformin. The FDA statement came a day after Singapore’s national health agency issued a recall of three metformin medications due to NDMA contamination. Multiple global health agencies, including Health Canada and the European Medicine Agency, announced similar probes investigating potential carcinogen contamination of metformin medications distributed worldwide.
Two months later, the FDA announced it found trace levels of NDMA contamination in metformin products but that those levels did not exceed the acceptable daily intake limit of 96 nanograms.
On March 2, 2020, the online pharmacy Valisure announced it had found unacceptably high levels of NDMA in 16 out of the 38 batches of metformin it tested. The contaminated batches were manufactured by 11 different drug companies, and the levels of NDMA contamination varied across batches. Some of the batches of contaminated metformin were found to contain over 10 times the acceptable daily limit.
After announcing its findings, Valisure filed a Citizen Petition requesting the FDA require a recall of metformin products it found to contain dangerous levels of NDMA and increase the quality of testing for NDMA in metformin. The petition stated that Valisure had followed the FDA’s recommended testing protocols but had made tweaks that it says improved the accuracy of the tests. Valisure had previously found unacceptably high levels of NDMA in the blood pressure medication Valsartan and the popular heartburn medication Zantac, both of which have experienced extensive recalls from the U.S. market.
On May 27, 2020, the FDA announced it had found high levels of NDMA in some lots of metformin medication.
NDMA is a probable human carcinogen that can form naturally or as a byproduct of a manufacturing process. Exposure to NDMA at levels beyond the daily acceptable intake limit has been linked to various cancers, including:
- Stomach cancer
- Bladder Cancer
- Intestinal cancer (in both the large and small intestine)
- Colon cancer/ colorectal cancer
- Esophageal cancer
- Liver cancer
- Prostate cancer
- Pancreatic cancer
- Non-Hodgkin’s Lymphoma
- Kidney Cancer
- Multiple Myeloma
Metformin is one of the most prescribed drugs in U.S. It is sold under the brand names of Glucophage, Glucophage XR, Fortamet, Riomet and Glumetza, and as a generic. Dozens of manufacturers produce and distribute metformin products in the U.S.
GoldenbergLaw is currently investigating cases where an individual has been diagnosed with cancer after taking metformin. Our Metformin Cancer Attorneys have been litigating complex pharmaceutical drug injury cases for over thirty years. Leave the sleepless nights to us.
Contact us today for a free consultation.Do I Qualify?
Metformin Lawsuit FAQs
If you have taken metformin and been diagnosed with cancer, you may be eligible to file a metformin lawsuit. Contact GoldenbergLaw today for a free case evaluation.
No batches of metformin have been recalled in the U.S. as of May 2020. Certain batches of metformin products in Canada and Singapore have recently been recalled due to NDMA contamination.
NDMA has been identified as a probable human carcinogen by the International Agency for Research on Cancer. It is considered a “probable” human carcinogen because there is not enough human data to conclude that it is a “known” carcinogen. However, numerous animal studies have found links between NDMA and cancers of the liver, respiratory tract, and blood vessels. Various U.S. health agencies, including the Department of Health and Human Services, have concluded that NDMA is “reasonably anticipated to be a human carcinogen.
If you have been diagnosed with cancer after taking metformin, you may be entitled to compensation for your injuries. Contact GoldenbergLaw for a free consultation and to learn more about a metformin cancer lawsuit.
If you or a loved one has been diagnosed with cancer after taking metformin, contact GoldenbergLaw today for a complementary metformin lawsuit consultation. Our Metformin Cancer Lawyers will fight to bring you justice. Leave the sleepless nights to us.Contact Us Call 800-903-1643
Why Choose GoldenbergLaw?
Our Minnesota cancer attorneys have litigating complex cases against pharmaceutical companies for over 30 years. Let us deliver the Gold standard advocacy you deserve.
Thousands of Successful Settlements
Comprehensive Knowledge of Complex Issues
Focused on Client-Centered Solutions
Meet Your Metformin Team
Have a potential client we could help?
Call us. You’ll sleep better.